---
id: 192
title: Diabetic Foot Infections
category: special_populations
subcategory: diabetes
tags: [diabetic-foot, osteomyelitis, IDSA, PEDIS, amputation, wound-care]
difficulty: high
---

## Question

How are diabetic foot infections managed? Use **"Probe-to-Bone+ or MRI = Osteo → Debride + Antibiotics (Mild: PO, Severe: IV Broad)"** framework.

## Answer

### **Classification (IDSA/PEDIS):**

| Severity | Clinical Features | Treatment Setting | Antibiotics |
|----------|-------------------|-------------------|-------------|
| **Mild** | Cellulitis ≤2 cm around ulcer, no systemic signs | Outpatient | PO narrow-spectrum |
| **Moderate** | Cellulitis >2 cm OR deep tissue involvement (abscess, fasciitis, joint, bone) OR systemic signs | Outpatient/Inpatient | PO/IV broad-spectrum |
| **Severe** | Systemic toxicity (fever, hypotension, AMS, ↑WBC) OR limb-threatening (ischemia, necrotizing fasciitis) | Inpatient | IV broad-spectrum |

### **Microbiology:**

**Mild (Superficial):**
- **Gram-positive cocci:** *S. aureus* (MSSA/MRSA), *Streptococcus* species

**Moderate-Severe (Deep):**
- **Polymicrobial:** *S. aureus*, streptococci, Gram-negative rods (*E. coli*, *Klebsiella*, *Pseudomonas*), anaerobes (*Bacteroides*, peptostreptococci)

**Risk Factors for MRSA:**
- Prior MRSA infection/colonization, recent antibiotics, recent hospitalization

**Risk Factors for *Pseudomonas*:**
- Maceration, frequent water exposure, prior antibiotics, chronic wounds

### **Osteomyelitis Diagnosis:**

**Clinical:**
- **Probe-to-bone test:** Sterile probe reaches bone through ulcer (sensitivity 60-95%, specificity 90-95%)
  - **Positive:** Osteomyelitis likely (if deep ulcer >2 cm²)

**Imaging:**

**MRI (Gold Standard):**
- **Sensitivity >90%, specificity >80%**
- **Findings:** Bone marrow edema, cortical destruction, soft tissue abscess

**Plain X-Ray:**
- **Low sensitivity** (50-70%), **high specificity** (>90%)
- **Findings:** Periosteal reaction, cortical erosion, bone lysis
- **Normal X-ray does NOT exclude** osteomyelitis (early disease)

**Bone Biopsy/Culture:**
- **Gold standard for microbiologic diagnosis**
- **Perform before antibiotics** (if possible)

**Inflammatory Markers:**
- **ESR >70 mm/h:** Suggests osteomyelitis (but NOT specific)

### **Empiric Antibiotics:**

**Mild (Outpatient, PO):**
- **Cephalexin 500mg PO QID** OR **clindamycin 300mg PO QID**
- **If MRSA risk:** TMP-SMX DS BID OR doxycycline 100mg BID

**Moderate (Outpatient PO or Inpatient IV):**
- **Levofloxacin 750mg PO/IV daily**
- OR **ampicillin-sulbactam 3g IV q6h**
- OR **ertapenem 1g IV daily**
- **If MRSA risk:** Add vancomycin 15-20 mg/kg IV q8-12h OR linezolid 600mg PO/IV BID

**Severe (Inpatient, IV Broad-Spectrum):**
- **Vancomycin 15-20 mg/kg IV q8-12h** (MRSA) + **piperacillin-tazobactam 3.375-4.5g IV q6-8h** (Gram-negatives + anaerobes)
- OR **vancomycin + cefepime 2g IV q8h + metronidazole 500mg IV q8h**

**Narrow Based on Cultures:**
- **Deep tissue or bone culture** (NOT superficial swab - contaminated)
- **Tailor to susceptibilities**

### **Duration:**

**Soft Tissue (No Osteomyelitis):**
- **1-2 weeks** (if improving clinically, wound healing)

**Osteomyelitis:**
- **Surgery (resection of infected bone):** **2-5 days** (if all infected bone removed)
- **No surgery (medical management):** **≥6 weeks** (total)
  - **IV × 2-4 weeks** → switch to PO (if improving, high bioavailability agent)

### **Surgical Management:**

**Debridement:**
- **Remove necrotic tissue, biofilm** (essential for healing)
- **Culture deep tissue/bone** (before antibiotics if possible)

**Revascularization:**
- **If peripheral arterial disease** (ankle-brachial index <0.9, non-healing ulcer)
- **Angiography + intervention** (angioplasty, bypass) improves healing

**Amputation:**
- **Limb-threatening infection** (necrotizing fasciitis, sepsis)
- **Failed medical/surgical management** (non-healing, persistent osteomyelitis)

### **Supportive Care:**

**Offloading:**
- **Total contact cast, walking boot** (reduce pressure on ulcer)
- **MOST important** for healing

**Glycemic Control:**
- **A1C <7%** improves wound healing

**Wound Care:**
- **Debridement, dressings** (moist environment)

## Key Points

### **Probe-to-Bone:**
- **Positive test = osteomyelitis likely** (if ulcer >2 cm², chronic)
- **MRI gold standard** if diagnosis unclear

### **Polymicrobial (Moderate-Severe):**
- **Gram-positives + Gram-negatives + anaerobes**
- **Broad-spectrum empiric** (vancomycin + pip-tazo OR cefepime + metronidazole)

### **Osteomyelitis Duration:**
- **Surgery (complete resection):** 2-5 days antibiotics
- **Medical management (no surgery):** ≥6 weeks

### **Offloading = Critical:**
- **Total contact cast** (gold standard)
- **Without offloading, antibiotics alone fail**

### **Culture Deep Tissue/Bone:**
- **NOT superficial swab** (contaminated with skin flora)
- **Biopsy/curettage** before antibiotics (if possible)

### **Clinical Pearls:**
- **Probe-to-bone + or MRI** = osteomyelitis → debride + antibiotics ≥6 weeks (or 2-5 days if resection)
- **Mild:** Outpatient PO (cephalexin, clindamycin)
- **Severe:** Inpatient IV broad (vancomycin + pip-tazo)
- **Offloading essential** (total contact cast)
- **Revascularization** if PAD (improves healing)

## Sources

- [IDSA: Diabetic Foot Infections Guidelines 2024]
- [CID: Osteomyelitis in Diabetic Foot 2024]

## Media

N/A
